News

Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...
In partnership with the Silicon Valley Business Journal, we'll honor the Bay Area's top companies recognized as the Best ...
Nice 23andMe sale hearing ya got there — shame if something happened to it, say attorneys for co-founder and former CEO who ...
Eikon Therapeutics announces layoffs, cutting 55 jobs due to reduced federal funding and biotech investment challenges.
Eli Lilly is expanding its efforts to advance next-generation pain medications. | Eli Lilly is expanding its efforts to ...
Story May 5 - Unity Biotechnology: Aging-focused Bay Area biotech Unity is laying off its entire workforce as the company pursues strategic alternatives, following the full results of a phase 2 ...
Macau, Macau Business, MAG, MB, MB Featured, MNA, MNA Featured | The first successful tech-to-industry enterprise from the ...
For the better part of six years, developers have their sights set on building a 2.5-million-square-foot biotechnology- and ...
A new era of medical science is taking shape in Massachusetts. Our biotech companies are at work on a gene therapy that can cure deafness, treatments that slow the effects of aging, and a ...
Uncooked cruciferous vegetables are high in fiber and can lead to belly bloat. “If you’re going to eat cruciferous vegetables ...
One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects.